Liberty Health (LHSIF) has been undergoing a series of dramatic changes at the management and Board level. It appears that the company is trying to revamp itself after Hindenburg Research released a report alleging the company of undisclosed insider dealings, inflated asset purchases, and dilutive share issuances. We think the company is likely to face near-term pressures due to a lack of leadership but the company still holds lots of potentials as a few options remain available to this Florida upstart. We suggest shareholders wait for new management before selling the stock.